PDL BIOPHARMA INC
(69329Y104)
Fondsberichterstattung Bestände von PDL BIOPHARMA INC gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| Dupont Capital Management Corp | 309,526 | $972k | Jun 30, 2019 | Jul 30, 2019 | |
| Acadian Asset Management LLC | 189,866 | $596k | Jun 30, 2019 | Aug 8, 2019 | |
| Crestline Management LP | 150,000 | $471k | Jun 30, 2019 | Aug 13, 2019 | |
| QS Investors LLC | 136,330 | $429k | Jun 30, 2019 | Aug 14, 2019 | |
| SMH Capital Advisors LLC | 85,368 | $268k | Jun 30, 2019 | Aug 5, 2019 | |
| Caxton Associates LP | 83,060 | $261k | Jun 30, 2019 | Aug 14, 2019 |